| 000 | 01835 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517161842.0 | ||
| 264 | 0 | _c20180618 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1878-1632 | ||
| 024 | 7 |
_a10.1016/j.spinee.2017.06.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCho, Jae Hwan | |
| 245 | 0 | 0 |
_aEfficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial. _h[electronic resource] |
| 260 |
_bThe spine journal : official journal of the North American Spine Society _c12 2017 |
||
| 300 |
_a1866-1874 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBone Morphogenetic Protein 2 _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Substitutes _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aDurapatite _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIlium _xtransplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSpinal Fusion _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLee, Jae Hyup | |
| 700 | 1 | _aYeom, Jin Sup | |
| 700 | 1 | _aChang, Bong-Soon | |
| 700 | 1 | _aYang, Jae Jun | |
| 700 | 1 | _aKoo, Ki Hyoung | |
| 700 | 1 | _aHwang, Chang Ju | |
| 700 | 1 | _aLee, Kwang Bok | |
| 700 | 1 | _aKim, Ho-Joong | |
| 700 | 1 | _aLee, Choon-Ki | |
| 700 | 1 | _aKim, Hyoungmin | |
| 700 | 1 | _aSuk, Kyung-Soo | |
| 700 | 1 | _aNam, Woo Dong | |
| 700 | 1 | _aHan, Jumi | |
| 773 | 0 |
_tThe spine journal : official journal of the North American Spine Society _gvol. 17 _gno. 12 _gp. 1866-1874 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.spinee.2017.06.023 _zAvailable from publisher's website |
| 999 |
_c27314034 _d27314034 |
||